Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda By: MarketWatch December 14, 2023 at 10:29 AM EST Moderna's stock was on track for its biggest one-day gain in more than a year. Read More >> Related Stocks: Merck & Co Moderna Inc
